MedTrace Logo

Comparison Of Efficacy Of Hydrocortisone And Methyl Prednisolone In Acute Severe Asthma

NCT06171932 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2023-12-15

No results posted yet for this study

Summary

COMPARISON OF EFFICACY OF HYDROCORTISONE AND METHYLPREDNISOLONE IN ACUTE SEVERE ASTHMA

In this study Investigator will compare the efficacy of hydrocortisone and methyl prednisolone in acute severe asthma that will lead to final result and beneficial effects that will help in early resoloution of symptoms and help in preventing recurrence

Conditions

  • Asthma Acute

Interventions

DRUG

Methylprednisolone,

No intervention required

Sponsors & Collaborators

  • University of Karachi

    lead OTHER

Principal Investigators

  • Inayat ur Rehman, MD ER · zia ud din university karachi

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-26
Primary Completion
2024-08-01
Completion
2024-08-08
FDA Drug
Yes

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06171932 on ClinicalTrials.gov